Raxibacumab, medically designated as PAmAb ABthrax, signifies a novel treatment approach against the disease . This single protein, designed by scientists, selectively binds to the protective factor of Bacillus anthracis, demonstrably neutralizing its capacity to cause harm. The process of Raxibacumab entails preventing toxin attachment to host cel